Australia seems poised to gain access to a groundbreaking therapy for weight issues: Retatrutide. This dual compound – acting on both GLP-1 and GIP receptors – shows promising efficacy in clinical studies, indicating substantial drops in body fat. While regulatory clearance remains with the Therapeutic Goods Administration (TGA), many Australia… Read More